Skip to main content

Table 2 FRS2 immunostaining and FISH results in 91ALT/WDLs and 91 DDLs

From: Expression of FRS2 in atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma: an immunohistochemical analysis of 182 cases with genetic data

FRS2 FISH

FRS2 immunostaining

Total

-(%)

1+ (%)

2+ (%)

3+ (%)

FRS2 amplified

6 (3.5%)

46 (26.7%)

63 (36.6%)

57 (33.2%)

172

 ALT/WDL

3 (3.6%)

31 (36.9%)

31 (36.9%)

19 (22.6%)

84

 DDL

3 (3.4%)

15 (17.0%)

32 (36.4%)

38 (43.2%)

88

FRS2 non-amplified

5 (50%)

5 (50%)

0 (0%)

0 (0%)

10

 ALT/WDL

5 (71.4%)

2 (28.6%)

0 (0%)

0 (0%)

7

 DDL

0 (0%)

3 (100%)

0 (0%)

0 (0%)

3

  1. ALT/WDL Atypical lipomatous tumor/well-differentiated liposarcoma, DDL Dedifferentiated liposarcoma, FISH fluorescence in situ hybridization, − negativity, 1+ weak positivity, 2+ moderate positivity, 3+ strong positivity